qPCR in the diagnosis of papillary thyroid cancer: Assessment of BRAF V600E mutation in FNA biopsies of thyroid nodules

被引：0
|
作者：
Gastelum-Quiroz, Anette R.
Ross-Orozco, Andrea
Alvarez-Arrazola, Marco A.
Arambula-Meraz, Eliakym
Morales-Hernandez, Karla L.
Tolosa-Lerma, Hanna M.
Luque-Ortega, Fred
Sanchez-Aboytes, Paola Y.
Garcia-Magallanes, Noemi
机构：
来源：
CANCER RESEARCH | 2024年 / 84卷 / 07期
关键词：
D O I：
10.1158/1538-7445.AM2024-LB276
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
LB276
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Quantitation of BRAF V600E alleles predicts papillary thyroid cancer progression
    Jung, Chan Kwon
    Kim, Min Hee
    Bae, Ja Seong
    Lim, Dong Jun
    Lee, Hyoungnam
    Jeon, So Ra
    Park, Gyeong Sin
    CANCER RESEARCH, 2014, 74 (19)
  • [42] Clinical utility of immunohistochemistry for the detection of the BRAF v600e mutation in papillary thyroid carcinoma
    Zagzag, Jonathan
    Pollack, Aron
    Dultz, Linda
    Dhar, Shumon
    Ogilvie, Jennifer B.
    Heller, Keith S.
    Deng, Fang-Ming
    Patel, Kepal N.
    SURGERY, 2013, 154 (06) : 1199 - 1204
  • [43] Identification of differentially expressed proteins in papillary thyroid carcinomas with V600E mutation of BRAF
    Puxeddu, Efisio
    Susta, Federica
    Orvietani, Pier Luigi
    Chiasserini, Davide
    Barbi, Flavia
    Moretti, Sonia
    Cavaliere, Antonio
    Santeusanio, Fausto
    Avenia, Nicola
    Binaglia, Luciano
    PROTEOMICS CLINICAL APPLICATIONS, 2007, 1 (07) : 672 - 680
  • [44] Quantification of BRAF V600E alleles predicts papillary thyroid cancer progression
    Kim, Min-Hee
    Bae, Ja Seong
    Lim, Dong-Jun
    Lee, Hyoungnam
    Jeon, So Ra
    Park, Gyeong Sin
    Jung, Chan Kwon
    ENDOCRINE-RELATED CANCER, 2014, 21 (06) : 891 - 902
  • [45] Correlation between Ultrasonographic Appearance of Papillary Thyroid Microcarcinoma and BRAF V600E Mutation
    Liang, Songnian
    Huang, Kun
    JOURNAL OF ONCOLOGY, 2022, 2022
  • [46] Impact of clinical risk scores and BRAF V600E mutation status on outcome in papillary thyroid cancer
    Niederer-Wuest, Severine M.
    Jochum, Wolfram
    Foerbs, Diana
    Braendle, Michael
    Bilz, Stefan
    Clerici, Thomas
    Oettli, Rene
    Mueller, Joachim
    Haile, Sarah R.
    Ess, Silvia
    Stoeckli, Sandro J.
    Broglie, Martina A.
    SURGERY, 2015, 157 (01) : 119 - 125
  • [47] Clinical Significance of PEAK1 Expression and BRAF V600E Mutation in Papillary Thyroid Cancer
    Li, P.
    Zhao, H.
    Liu, X.
    Huang, Y.
    Chen, D.
    BRITISH JOURNAL OF BIOMEDICAL SCIENCE, 2022, 79
  • [48] Influence of the BRAF V600E mutation on expression of vascular endothelial growth factor in papillary thyroid cancer
    Jo, Young Suk
    Li, Shengjin
    Song, Jung Hun
    Kwon, Ki Hyun
    Lee, Jun Chul
    Rha, So Young
    Lee, Hyo Jin
    Sul, Ji Young
    Kweon, Gi Ryang
    Ro, Heung-kyu
    Kim, Jin-Man
    Shong, Minho
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2006, 91 (09): : 3667 - 3670
  • [49] BRAF V600E mutation in papillary thyroid cancer is correlated with adverse clinicopathological features but not with iodine exposure
    Ozcelik, Serhat
    Bircan, Rifat
    Sarikaya, Sukran
    Gul, Aylin E.
    Aydin, Busra
    Ozcelik, Melike
    Celik, Mehmet
    Dayan, Akin
    Tutuncu, Yasemin
    Cengiz, Hasret
    Karadayi, Nimet
    Gozu, Hulya Iliksu
    ENDOKRYNOLOGIA POLSKA, 2019, 70 (05) : 401 - 408
  • [50] BRAF V600E and BRAF-WT Specific Antitumor Immunity in Papillary Thyroid Cancer
    Ehlers, Margret
    Schmidt, Mathias
    Mattes-Gyorgy, Katalin
    Antke, Christina
    Enczmann, Juergen
    Schlensog, Martin
    Japp, Anna
    Haase, Matthias
    Allelein, Stephanie
    Dringenberg, Till
    Giesel, Frederik
    Esposito, Irene
    Schott, Matthias
    HORMONE AND METABOLIC RESEARCH, 2022, 54 (12) : 852 - 858
12345